Flemington, NJ, United States of America

Xiao-Ping Li

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Xiao-Ping Li

Introduction

Xiao-Ping Li is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the area of ribosome inactivating proteins. With a total of 2 patents, his work has implications for medical treatments and toxin management.

Latest Patents

Xiao-Ping Li's latest patents include innovative methods for addressing the toxicity caused by ribosome inactivating proteins. One of his patents, titled "Compositions and methods for inhibiting ribosome inactivating proteins," provides a method for treating, ameliorating, and preventing toxicity in subjects. This method involves administering a therapeutically effective amount of at least one compound from the disclosure. Another significant patent is "Ricin ribosome binding protein compositions and methods of use thereof," which outlines compositions and methods for the treatment of toxin poisoning.

Career Highlights

Xiao-Ping Li is affiliated with Rutgers, the State University of New Jersey, where he continues to advance research in his field. His work is characterized by a commitment to developing practical solutions for serious health issues related to toxin exposure.

Collaborations

Xiao-Ping Li collaborates with several professionals in his field, including Nilgun Ereken Tumer and Nilgun E Tumer, who contribute to his research efforts.

Conclusion

Xiao-Ping Li's innovative patents and research at Rutgers University highlight his important role in the scientific community. His contributions to the understanding and treatment of ribosome inactivating proteins are paving the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…